Agios Pharmaceuticals Inc

AGIONASDAQ · USD
35.00USD+1.05 (+3.10%)
235

Agios Pharmaceuticals Inc (AGIO) Implied Volatility Current

AGIO implied volatility is 70%. IV Rank is 64%, placing current premiums in the middle of their 52-week range.

Read more

Tracking AGIO implied volatility helps you identify when options premiums on Agios Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Agios Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when AGIO IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Agios Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For AGIO, tracking metrics like AGIO IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on AGIO signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where AGIO implied volatility sits today versus where it has been. Our scanner ranks Agios Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in AGIO IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Agios Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
63.89%IV Rank
Moderate

IV is slightly elevated - premiums are richer, leaning toward sellers.

Implied Volatility (30d)69.89%

IV Rank63.89%

Historical Volatility (30d)33.73%

IV - HV+36.16%

As of September 21, 2026

Trade options with IV on your side

Track AGIO IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial